Buscar resultados de ensayos clínicos
Fibromatosis, Aggressive - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Toremifene in Treating Patients With Desmoid Tumors Condición: Desmoid Tumor Fecha: 1999-11-01 Intervenciones:
|
Completed |
Nombre del estudio: Vinblastine and Methotrexate in Treating Children With Desmoid Tumors Condición: Desmoid Tumor Fecha: 2000-08-03 Intervenciones:
|
Completed |
Nombre del estudio: Radiation Therapy in Treating Patients With Aggressive Fibromatoses Condición: Desmoid Tumor Fecha: 2002-02-14 Intervenciones: Radiation: radiation therapy |
Recruiting |
Nombre del estudio: PAZOPANIB Efficacy and Tolerance in Desmoids Tumors Condición: Progressive Desmoids Tumors Fecha: 2012-11-06 Intervenciones:
|
Recruiting |
Nombre del estudio: A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Condición: Desmoid Tumor Fecha: 2010-12-06 Intervenciones: Drug: Sirolimus
|
Active, not recruiting |
Nombre del estudio: Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor Condición: Desmoid Tumor Fecha: 2003-09-10 Intervenciones:
|
Recruiting |
Nombre del estudio: Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment Condición: Desmoid Tumors Fecha: 2015-06-04 Intervenciones: Device: "cryoprobes" Patient undergo percutaneous cryoablation of desmoid tumor, with cryoprob |
Recruiting |
Nombre del estudio: National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) Condición: Aggressive Fibromatosis Fecha: 2016-07-15 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis Condición:
|
Active, not recruiting |
Nombre del estudio: Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Condición: Desmoid Type-fibromatosis Fecha: 2015-01-28 Intervenciones: Drug: Toremifene Patients will receive 60 mg daily and then 180 daily in case of progression |